Saw palmetto is vital to native landscape
Unlike many Florida Keys palms, saw palmetto is one of 14 palms native to Florida. It is not surprising because it can survive inundation by flooding or burning to the
Source: keysnews.com
📰 Prostate News
Page 118 - Prostate News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prostate. Real-time updates on events, politics, business and more.
Researchers develop influenza virus-like particle-based hybrid vaccine for both influenza and SARS-CoV-2 viruses
In a new study, a team of researchers developed a hybrid vaccine for SARS-CoV-2 and influenza viruses using influenza virus-like particles (VLP).
Aimee Molineux Neha Mathur Neha Mathurfeb Lunla Shutterstock Image Credit Coronavirus Disease Covid 19
Source: news-medical.net
Ultimovacs ASA: Ultimovacs to Progress to Last Cohort in Phase I Prostate Cancer TENDU study
No safety concerns found in first two dose level cohortsEnables progression to highest dosing level in assessment of Ultimovacs' second vaccine technology platform Oslo, 3 February 2022: Ultimovacs
Joachim Midttun Mary Ann Chang Company Tetanus Oslo University Hospital Tetanus Epitope Targeting Drug Safety Monitoring Board
Source: finanznachrichten.de
New approach accelerates the detection of cancer biomarkers for point-of-care diagnostics
The detection and quantification of cancer-associated molecular biomarkers in body fluids, or liquid biopsies, prove minimally invasive in early cancer diagnostics.
United States Congnyu Che Brian Cunningham Emily Henderson Huntsman Cancer Institute National Institutes Of Health
Source: news-medical.net
Blood test and MRI combination in prostate cancer screening can reduce overdiagnosis, societal costs
The combination of a novel blood test and magnetic resonance imaging (MRI) can reduce overdiagnosis of low-risk cancers as well as societal costs in prostate cancer screening, according to a cost-effectiveness study from Karolinska Institutet published in the journal European Urology.
Tobias Nordstr Karolinska Institutet Mark Clements Emily Henderson Swedish National Board Of Health Department Of Clinical Sciences
Source: news-medical.net
Telix Pharmaceuticals Limited: Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus
MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive commercial
United States Kyahn Williamson Angelos Pagonis Richard Valeix Unitedstatesandmaynotbeofferedorsoldwithintheunited States Christian Behrenbruch
Source: finanznachrichten.de
Death rates from ovarian cancer are predicted to fall by 2022 in EU countries
Death rates from ovarian cancer are predicted to fall by 17% in the UK and by 7% in EU countries in 2022 compared to 2017, according to new research published in the leading cancer journal Annals of Oncology today (Wednesday).
United Kingdom Eva Negri Emily Henderson Stony Brook University World Health Organization University Of Milan
Source: news-medical.net
The Role of Glycans in the Cell and Glycans Imaging Method
In this interview, News-Medical talks to a pioneer of glycan imaging, Richard Drake about glycans, their role in maintaining cellular homeostasis, glycopeptide analysis, and method development for glycan imaging.
Source: news-medical.net
Faulty BRCA genes, known to increase breast cancer risk, now linked to prostate and pancreatic cancers
If outside factors like exposure to pesticides, smog and pollution werent enough, internal factors like faulty versions of the BRCA1 and BRCA2 genes, have now been linked to several other cancers, including those that affect men.
United Kingdom Marc Tischkowitz Antonis Antoniou Michelle Mitchell University Of Cambridge Department Of Medical Genetics
Source: webindia123.com
Telix Pharmaceuticals Limited: First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
MELBOURNE, Australia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company's prostate-specific
United States Kyahn Williamson Colin Hayward Kenneth Obyrne Telix Prost Unitedstatesandmaynotbeofferedorsoldwithintheunited States
Source: finanznachrichten.de